Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

GlyT-1 Inhibitor Treatment for Refractory Schizophrenia

This study has been completed.
Information provided by (Responsible Party):
Hsien-Yuan Lane, China Medical University Hospital Identifier:
First received: November 3, 2010
Last updated: October 27, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)